{"name":"Array BioPharma","slug":"array-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":173768000,"revenueGrowth":390.4,"grossMargin":0,"rdSpend":185821000,"netIncome":-147346000,"cash":460364000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"ARRY-142886, MEK inhibitor; oral","genericName":"ARRY-142886, MEK inhibitor; oral","slug":"arry-142886-mek-inhibitor-oral","indication":"Solid tumors","status":"phase_1"},{"name":"ARRY-300, MEK inhibitor; oral","genericName":"ARRY-300, MEK inhibitor; oral","slug":"arry-300-mek-inhibitor-oral","indication":"Non-small cell lung cancer","status":"phase_1"},{"name":"ARRY-382, cFMS inhibitor; oral","genericName":"ARRY-382, cFMS inhibitor; oral","slug":"arry-382-cfms-inhibitor-oral","indication":"Solid tumors","status":"phase_1"},{"name":"ARRY-438162, MEK inhibitor; oral","genericName":"ARRY-438162, MEK inhibitor; oral","slug":"arry-438162-mek-inhibitor-oral","indication":"Metastatic non-small cell lung cancer","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ARRY-403, glucokinase activator; oral","genericName":"ARRY-403, glucokinase activator; oral","slug":"arry-403-glucokinase-activator-oral","indication":"Type 2 diabetes","status":"phase_1"}]}],"pipeline":[{"name":"ARRY-142886, MEK inhibitor; oral","genericName":"ARRY-142886, MEK inhibitor; oral","slug":"arry-142886-mek-inhibitor-oral","phase":"phase_1","mechanism":"MEK inhibitor","indications":["Solid tumors"],"catalyst":""},{"name":"ARRY-300, MEK inhibitor; oral","genericName":"ARRY-300, MEK inhibitor; oral","slug":"arry-300-mek-inhibitor-oral","phase":"phase_1","mechanism":"MEK inhibitor","indications":["Non-small cell lung cancer"],"catalyst":""},{"name":"ARRY-382, cFMS inhibitor; oral","genericName":"ARRY-382, cFMS inhibitor; oral","slug":"arry-382-cfms-inhibitor-oral","phase":"phase_1","mechanism":"cFMS inhibitor","indications":["Solid tumors"],"catalyst":""},{"name":"ARRY-403, glucokinase activator; oral","genericName":"ARRY-403, glucokinase activator; oral","slug":"arry-403-glucokinase-activator-oral","phase":"phase_1","mechanism":"Glucokinase activator","indications":["Type 2 diabetes"],"catalyst":""},{"name":"ARRY-438162, MEK inhibitor; oral","genericName":"ARRY-438162, MEK inhibitor; oral","slug":"arry-438162-mek-inhibitor-oral","phase":"phase_2","mechanism":"Inhibits MEK, a protein involved in the MAPK/ERK signaling pathway, which is often dysregulated in cancer.","indications":["Metastatic non-small cell lung cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTGtodFI4WEJSZUNIMzMzbWtqSGJ0SDF2a21JT0RSYW92RGJCdEFNdzkxVEtUZzYtbGpGdkQ5TmNNY05MSUpJRVNhaWx5bXgwbk5SSHZLRG1oMS1nUllqV3VSdlZnbFo3dlktakFWLWR6dWpiWjQ4WWNNZWhCOEdicEdpU1haUkpLbm1malNBSmYtdy1ETFFLTVFmWWVXY2JqSmJrTExZSENTMHVkZEJzbkVHN0pHNnJo?oc=5","date":"2023-10-19","type":"deal","source":"Fierce Biotech","summary":"Array BioPharma employee's husband accused of making $90K from insider trading before Pfizer buy - Fierce Biotech","headline":"Array BioPharma employee's husband accused of making $90K from insider trading before Pfizer buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOWlZEWXVLRFNvM212Zm9taExWbGhHblRheW1GYUhiYVQxQ0Y5NWJPQnVHdXVMaTljNG54SWdwOVotcUpQQU1idFp2eDQ2YU9abU03TDdhUXJucHdWd19ReVdXSU9rT05TQUdXc0xTeUkzWjVHdVZQOEFSMlpxaWIxeDRFS3RXZU1DN000V1FvSUZaUkRCUmc?oc=5","date":"2023-05-26","type":"pipeline","source":"bizjournals.com","summary":"Founder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round - bizjournals.com","headline":"Founder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNQTdUMTFSQkVvZ0Q5ZnM3emxlS3QydGticTlvamFUc0VSeDFqTDJQa2dwZUE2ak1zTUxiVTY0SFFSeDB6TGFmUTNzcTFIRzQyMUgzdVdIR2t0U2FhUlRUb2hCV0NsTEVtNjF3YXVuTkhXeVZUX19JNENqQ0tsQy1MMjUxallxMG4waGNnYTQyRGxOQkViQmZ1c0U5V1l0VXJPMEZIbVJWeTRkN1Y1QlRmX00xc0NHUkdK?oc=5","date":"2019-07-01","type":"deal","source":"Fierce Pharma","summary":"Array played with Pfizer's eagerness to land a deal on time—and got itself a better offer - Fierce Pharma","headline":"Array played with Pfizer's eagerness to land a deal on time—and got itself a better offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQX3p0MzhteUQ2eUt2azFzX1NCMHFid0FReHhqbDF0c2IteW5VM3NmU2xlcVZDYWNaSGVzZEx2U1VfcUhoLW1YLUhTV0oyMWRuTGpWeUxrVXZiZnhvSGhRZnhHRGxxalo3RERmMkt1QWRmTkt1YlBub2JWYkd2dS13bXBpVDMwR0xOUVBYck44amw2T3JJTnNKc1RILUpOb2NtN1pBYw?oc=5","date":"2019-06-17","type":"deal","source":"Fierce Pharma","summary":"Pfizer, 'never say never' with big M&A, inks $11.4B Array cancer deal - Fierce Pharma","headline":"Pfizer, 'never say never' with big M&A, inks $11.4B Array cancer deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNR1gwRkNjVkdMTDdOR1kyNEpSTHUteDVuYzAtZENrYUhnY1RkeVRsS0N3Uldobl9kMmVqUkhQS3FEbklYbHJrUlRpTnhwbEctWVdTYm9KYmdVLWJTZEh3WC1fZzhlQTJnbVktaVdibkEwTkZtZ3B2TTg3WmRXUFZwdUNaei12S1B6LVNMcUsxZHJNUDVETTdjUWVCNG1TRVlHZjk4WTZiMEsxRU0?oc=5","date":"2019-06-17","type":"deal","source":"BioPharma Dive","summary":"Pfizer goes big on targeted cancer therapies with $11.4B Array buy - BioPharma Dive","headline":"Pfizer goes big on targeted cancer therapies with $11.4B Array buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQRWdhd011WHprVllQS0ZXLU9ralNGQWZqSnNqYTVoV2xmTFRGZ0hfSEpQc1BBOFFYY0xFN0lFR1liaGcwSkRwN3ExTTRDYVd1S1FQcjVqUXhVVm03VTA3Qkh0NDY0UFBaVTNRSEQ0LXJiR3R0Q3JmSnJQeUtmanl3UTdncENSbTI0bWFNZ05uX1dyVknSAZgBQVVfeXFMUHR2OFdnZk52bEtPYzg4aER4YUNIOXp6V1UyNURCUkNkVVFBUDV1eGhvWkFJWDVfQWV6TnhnZnRWc3hPNHR5RjFCbWZiY0dTTUtGZHc2bW9zS3BnS1EwMXlpNVJXVjZXUGJtOXpLSUZSQTJ0M0t0QWtrM0xVaWV1NDlvcHM0UlNrSHNIeWFGVEpvM1JDX1NuQm4?oc=5","date":"2019-06-17","type":"deal","source":"CNBC","summary":"Pfizer bolsters its cancer portfolio with a $10.64 billion deal for Array - CNBC","headline":"Pfizer bolsters its cancer portfolio with a $10.64 billion deal for Array","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOQ1I0dTdMM0ctVlRSR01PejdtLVVYR0ljeW9IWEtaR29DX1JCZUI2dVhNcFFCajIwRjh3V0ZLaXBRTnhCbl9rRngxTU1ZZ0QtYlp6TEFkelVCUUw2S0FyckxBVmdJbVN0RTlFbWIyeHczWjh4ZzhSYjFDa2lGV1NfOHpMR05QZW5RcDBybXpMZGxTTWZ2S0NaT2dn?oc=5","date":"2019-06-17","type":"deal","source":"statnews.com","summary":"Pfizer spends $11.4 billion to buy Array BioPharma for its cancer drug chemistry - statnews.com","headline":"Pfizer spends $11.4 billion to buy Array BioPharma for its cancer drug chemistry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQSFl2elN3QjFNTXY0YlJDSXAxYktuYkhYZWQ5dmV1NkoxM1BPVk0yc2tOYmNYbTNWRXdQaTBNd0JrRmJWSzdyQjFoN3UwaUQtZWs0aEdZQjUxR1BaOUlKMmxhZ2I1bGpHZFBKamVKUFRzakFvVUcxNW9xWURBbDNEQlozdzdPMlF4UG5JNFotQXI3ZmRpMWJQbWtNa0hMZVdTWjZwVw?oc=5","date":"2019-06-17","type":"pipeline","source":"Business Insider","summary":"Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer - Business Insider","headline":"Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPajY4Y0Rwbm1yWC1EajRDbncxV184UXFVZktpaUpNd1ZZS0NPVDlORE5kMW1lMUNUd0wtNlN6anI2SVNmN0pQbHREb0xwNjMzd1djbS15Wi0tNkg5SkFkeno0YUVfVXAwNS05Q2lkOVF6a0FKRnNkUHZKOGpMcEFHWUF1QQ?oc=5","date":"2019-06-17","type":"deal","source":"Axios","summary":"Pfizer buys Array BioPharma for $11.4 billion - Axios","headline":"Pfizer buys Array BioPharma for $11.4 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOWmRFYktjODN4MkJaR3FoZXk5QlJob1J4UnlkejJmUzFIMW55WU9VTkxERHNpRElzYWROWlJVc2lGWHRlTVV6bDdkZUp1Tm5BQXp2Uzc2R1BfeGZUV0ZyQWMzSWdOcUcxeE5OOUs3SmlIaUpXdWNTbld4QzZDVzVmTmtYLWgzT2wwNnhWY1I0MmhiZw?oc=5","date":"2019-06-17","type":"deal","source":"pharmaphorum","summary":"As Lyrica patent expiry looms, Pfizer buys Array for $11.4bn - pharmaphorum","headline":"As Lyrica patent expiry looms, Pfizer buys Array for $11.4bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNel91VjQ5Tk1HbTlqa19SUTlrZXR4bHFuRHRQLVBTZ1RKekhKT0l5a3hCaHYyRlMyaVBCX3RaT1pKa2VUYjl0UkQyWThYamRJNVotOUdXOU9hb2lZUGNqNl9VVUxDX01OenhUei0xOVlyNmZYY3VhU01VVWM4anBVa0V2WQ?oc=5","date":"2019-06-17","type":"pipeline","source":"BioSpace","summary":"Pfizer Strengthens Oncology Pipeline with $11.4 Billion Acquisition of Array BioPharma - BioSpace","headline":"Pfizer Strengthens Oncology Pipeline with $11.4 Billion Acquisition of Array BioPharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNZHBxbTkzRXR1Y2hVZVI5OUpKQ3Nja3VDSUpHTk0wZ3FXNUlqMWI3aTFWSldHelh3WllPYjB2VGJaQVFfVXJEWDZpdXpWQjY5eHRjR05KVGJPcTdmYUlzTFhZOHFtcnJaOEJlbXExZDdEUWNoTjhZVmZxWEJSRkVuUUdHSFVNVkNEVVhBWTdlU2F2YnNxTEE0SElrcWN6RzNUdEJ5UFRXUVVBREYtb0VwUVBUUFFleFFNTndCdmhLbUxoWVI3eTR3LXk3Zl9kZU0tQ2VVaDhYVmQtNzBOVy1JQUs3RXJSOUtzR0R5SXVXWEFNcnJlVzJLZ1hsYW9LcWdtdzJlRzlLbm45Tkg5RW5Za0FnMHp3UlR1RnJLc3hyajdZWGZPOGJIc1VmZ0NaNzdZcjA0RkZDOFJnUWlvcEJHaTUzam8tc1V2d3hJ?oc=5","date":"2017-05-31","type":"deal","source":"PR Newswire","summary":"Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib - PR Newswire","headline":"Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For T","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":4,"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":173768000,"revenuePeriod":"2018-06-30","revenueHistory":[{"value":173768000,"period":"2018-06-30"},{"value":35437000,"period":"2018-06-30"},{"value":66367000,"period":"2018-03-31"},{"value":42218000,"period":"2017-12-31"},{"value":29746000,"period":"2017-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":185821000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-147346000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":460364000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}